Systemic cell therapy for muscular dystrophies: The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy

The intrinsic regenerative capacity of skeletal muscle makes it an excellent target for cell therapy. However, the potential of muscle tissue to renew is typically exhausted and insufficient in muscular dystrophies (MDs), a large group of heterogeneous genetic disorders showing progressive loss of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ausems, C. Rosanne M., van Engelen, Baziel G.M., van Bokhoven, Hans, Wansink, Derick G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166694/
https://www.ncbi.nlm.nih.gov/pubmed/33349909
http://dx.doi.org/10.1007/s12015-020-10100-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166694/
https://www.ncbi.nlm.nih.gov/pubmed/33349909
http://dx.doi.org/10.1007/s12015-020-10100-y

Ejemplares similares